SCHEMBL6300780

SCHEMBL6300780

NS(=O)(=O)c1ccc(-c2coc(=O)n2-c2ccc(Cl)c(Cl)c2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 20/20 1.00
PTGS1 P23219 18/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6308147 0.88 PTGS2 (0.78) PTGS2PTGS1
SCHEMBL4576392 0.86 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL13943912 0.85 PTGS2 (0.74) PTGS2PTGS1
SCHEMBL8724654 0.85 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL8070399 0.82 PTGS2 (0.74) PTGS2PTGS1
SCHEMBL6725774 0.82 PTGS2 (0.70) PTGS2PTGS1
SCHEMBL6732850 0.82 PTGS2 (0.69) PTGS2PTGS1
SCHEMBL4575048 0.81 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL8068392 0.81 PTGS2 (0.76) PTGS2PTGS1
SCHEMBL2126159 0.81 PTGS2 (1.00) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6869968-B1 Such as 3-(4-fluorophenyl)-4-(4-methysulphonylphenyl)-2-(3H)-oxazolone; for treating colorectal cancer, fevers, and inflammation ALLMIRALL PRODESFARMA S.A. (ES) 2005-03-22 US claimed
EP-0888316-B1 2-(3H)-OXAZOLONE DERIVATIVES AND THEIR USE AS COX-2 INHIBITORS ALMIRALL PRODESFARMA SA (ES) 2000-11-02 EP claimed
WO-1998011080-A1 NOVEL 3,4-DIARYLOXAZOLONE DERIVATIVES, METHODS OF PREPARATION AND THERAPEUTIC USES THEREOF LABORATOIRES UPSA (FR) 1998-03-19 WO claimed
US-6869968-B1 Such as 3-(4-fluorophenyl)-4-(4-methysulphonylphenyl)-2-(3H)-oxazolone; for treating colorectal cancer, fevers, and inflammation ALLMIRALL PRODESFARMA S.A. (ES) 2005-03-22 US disclosed
EP-0888316-B1 2-(3H)-OXAZOLONE DERIVATIVES AND THEIR USE AS COX-2 INHIBITORS ALMIRALL PRODESFARMA SA (ES) 2000-11-02 EP disclosed
EP-0888316-A1 2-(3H)-OXAZOLONE DERIVATIVES AND THEIR USE AS COX-2 INHIBITORS ALMIRALL-PRODESFARMA, S.A. (ES) 1999-01-07 EP disclosed
WO-1998011080-A1 NOVEL 3,4-DIARYLOXAZOLONE DERIVATIVES, METHODS OF PREPARATION AND THERAPEUTIC USES THEREOF LABORATOIRES UPSA (FR) 1998-03-19 WO disclosed
WO-1997034882-A1 2-(3H)-OXAZOLONE DERIVATIVES AND THEIR USE AS COX-2 INHIBITORS ALMIRALL PRODESFARMA, S.A. (ES) 1997-09-25 WO disclosed